AC Immune SA logo
AC Immune SA ACIU
$ 2.75 1.88%

Annual report 2023
added 12-21-2024

report update icon

AC Immune SA Balance Sheet 2011-2024 | ACIU

Annual Balance Sheet AC Immune SA

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

- - -191 M -156 M -124 M -152 M -76.5 M -3.31 M - - -

Long Term Debt

- - - - 1.81 M 186 K 395 K - - - - - -

Long Term Debt Current

672 K 548 K 570 K 443 K 442 K - - - - - - - -

Total Non Current Liabilities

- - - 9.24 M 9.3 M 5.85 M 5.42 M 3.8 M 2.79 M 2.41 M - - -

Total Current Liabilities

- - - - - - - - - - - - -

Total Liabilities

22.2 M 16.9 M 29.5 M 23.3 M 26.8 M 18.9 M 15.2 M 13.7 M 8.89 M 6.83 M - - -

Deferred Revenue

- - - 306 K 4.48 M 351 K 355 K 521 K - 205 K - - -

Retained Earnings

- - - -133 M -75.5 M -122 M -72.6 M -46.9 M -40.4 M -60.5 M - - -

Total Assets

183 M 186 M 261 M 239 M 299 M 197 M 132 M 156 M 79.9 M 30.3 M - - -

Cash and Cash Equivalents

78.5 M 31.6 M 82.2 M 161 M 194 M 156 M 124 M 152 M 76.5 M - - - -

Book Value

161 M 169 M 232 M 215 M 272 M 178 M 117 M 142 M 71 M 23.5 M - - -

Total Shareholders Equity

- - - 215 M 272 M 178 M 117 M 142 M 71 M - - - -

All numbers in CHF currency

Quarterly Balance Sheet AC Immune SA

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

- - - - 2.34 M - - - 1.78 M - - - 1.81 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Non Current Liabilities

- - - - 9.44 M - - - 9.24 M - - - 9.3 M - - - 5.85 M - - - 5.42 M - - - 3.8 M - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

- - - - 29.5 M - - - 23.3 M - - - 26.8 M - - - 18.9 M - - - 15.2 M - - - 13.7 M - - - - - - - - - - - - - - - - - - - - - - -

Deferred Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Retained Earnings

- - - - -201 M - - - -133 M - - - -75.5 M - - - -122 M - - - -72.6 M - - - -46.9 M - - - - - - - - - - - - - - - - - - - - - - -

Total Assets

- - - - 261 M - - - 239 M - - - 299 M - - - 197 M - - - 132 M - - - 156 M - - - - - - - - - - - - - - - - - - - - - - -

Cash and Cash Equivalents

- - - - 82.2 M - - - 161 M - - - 194 M - - - 156 M - - - 124 M - - - 152 M - - - 76.5 M - - - 3.31 M - - - - - - - - - - - - - - -

Book Value

- - - - 232 M - - - 215 M - - - 272 M - - - 178 M - - - 117 M - - - 142 M - - - - - - - - - - - - - - - - - - - - - - -

Total Shareholders Equity

- - - - 232 M - - - 215 M - - - 272 M - - - 178 M - - - 117 M - - - 142 M - - - 71 M - - - 23.5 M - - - - - - - - - - - - - - -

All numbers in CHF currency